Wikidata entity: Q18216
C₉H₈O₄ (P274)


Quantities
| P2107 | decomposition point | 284 |
| P2054 | density | 1.35 |
| P2067 | mass | 180.042 |
| P2240 | median lethal dose (LD50) | 167 |
| P2240 | median lethal dose (LD50) | 200 |
| P2240 | median lethal dose (LD50) | 250 |
| P2240 | median lethal dose (LD50) | 340 |
| P2240 | median lethal dose (LD50) | 495 |
| P2240 | median lethal dose (LD50) | 681 |
| P2240 | median lethal dose (LD50) | 700 |
| P2240 | median lethal dose (LD50) | 790 |
| P2240 | median lethal dose (LD50) | 1010 |
| P2240 | median lethal dose (LD50) | 1020 |
| P2240 | median lethal dose (LD50) | 1075 |
| P2240 | median lethal dose (LD50) | 1750 |
| P2240 | median lethal dose (LD50) | 3500 |
| P2101 | melting point | 135 |
| P2300 | minimal lethal dose | 104 |
| P2300 | minimal lethal dose | 294 |
| P2300 | minimal lethal dose | 1216 |
| P2204 | minimum explosive concentration | 40 |
| P1117 | pKa | 3.49 |
| P2407 | short-term exposure limit | 0.5 |
| P2177 | solubility | 0.003 |
| P2404 | time-weighted average exposure limit | 5 |
| P2119 | vapor pressure | 0 |
| P3780 | active ingredient in | ... | Q10420388 (Aspirin) | Aspirin |
| P3780 | active ingredient in | ... | Q47521514 (Durlaza) | Durlaza |
| P3335 | associated hazard | ... | Q21167614 (acetylsalicylic acid exposure) | acetylsalicylic acid exposure |
| P166 | award received | ... | Q1366018 (National Inventors Hall of Fame) | National Inventors Hall of Fame |
| P1716 | brand | ... | Q10420388 (Aspirin) | Aspirin |
| P233 | canonical SMILES | String | CC(=O)OC1=CC=CC=C1C(=O)O | ??? |
| P373 | Commons category | String | Acetylsalicylic acid | ??? |
| P1343 | described by source | ... | Q123560817 (Armenian Soviet Encyclopedia, vol. 1) | Armenian Soviet Encyclopedia, vol. 1 |
| P1343 | described by source | ... | Q602358 (Brockhaus and Efron Encyclopedic Dictionary) | Brockhaus and Efron Encyclopedic Dictionary |
| P1343 | described by source | ... | Q19180675 (Small Brockhaus and Efron Encyclopedic Dictionary) | Small Brockhaus and Efron Encyclopedic Dictionary |
| P1343 | described by source | ... | Q20078554 (Great Soviet Encyclopedia (1926–1947)) | Great Soviet Encyclopedia (1926–1947) |
| P1343 | described by source | ... | Q2041543 (???) | ??? |
| P1889 | different from | ... | Q10420388 (Aspirin) | Aspirin |
| P61 | discoverer or inventor | ... | Q76618 (Arthur Eichengrün) | Arthur Eichengrün |
| P61 | discoverer or inventor | ... | Q61232 (Felix Hoffmann) | Felix Hoffmann |
| P61 | discoverer or inventor | ... | Q446900 (Charles Frédéric Gerhardt) | Charles Frédéric Gerhardt |
| P703 | found in taxon | ... | Q257106 (liquorice) | liquorice |
| P1552 | has characteristic | ... | Q1517187 (bitterness) | bitterness |
| P1552 | has characteristic | ... | Q21073023 (combustible powder) | combustible powder |
| P1542 | has effect | ... | Q826103 (Reye syndrome) | Reye syndrome |
| P1542 | has effect | ... | Q21167614 (acetylsalicylic acid exposure) | acetylsalicylic acid exposure |
| P527 | has part(s) | ... | Q556 (hydrogen) | hydrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P366 | has use | ... | Q12140 (medication) | medication |
| P366 | has use | ... | Q35456 (essential medicine) | essential medicine |
| P2572 | hashtag | String | aspirin | ??? |
| P2184 | history of topic | ... | Q5867393 (history of aspirin) | history of aspirin |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q26715239 (General sales list (UK)) | General sales list (UK) |
| P4954 | may prevent disease | ... | Q12152 (myocardial infarction) | myocardial infarction |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q101991 (inflammation) | inflammation |
| P2175 | medical condition treated | ... | Q190805 (heart disease) | heart disease |
| P2175 | medical condition treated | ... | Q242165 (hyperthermia) | hyperthermia |
| P2175 | medical condition treated | ... | Q62736 (osteoarthritis) | osteoarthritis |
| P2175 | medical condition treated | ... | Q12152 (myocardial infarction) | myocardial infarction |
| P2175 | medical condition treated | ... | Q266018 (acute coronary syndrome) | acute coronary syndrome |
| P2175 | medical condition treated | ... | Q187255 (rheumatoid arthritis) | rheumatoid arthritis |
| P2175 | medical condition treated | ... | Q753904 (rheumatic fever) | rheumatic fever |
| P2175 | medical condition treated | ... | Q815819 (atrial fibrillation) | atrial fibrillation |
| P2175 | medical condition treated | ... | Q6081223 (gout attack) | gout attack |
| P2175 | medical condition treated | ... | Q18558122 (acute myocardial infarction) | acute myocardial infarction |
| P1705 | native label | Monolingualtext | Acidum acetylsalicylicum | ??? |
| P1931 | NIOSH Pocket Guide ID | String | 0010 | ??? |
| P129 | physically interacts with | ... | Q415364 (Prostaglandin-endoperoxide synthase 2) | Prostaglandin-endoperoxide synthase 2 |
| P129 | physically interacts with | ... | Q21102111 (Acid sensing ion channel subunit 3) | Acid sensing ion channel subunit 3 |
| P129 | physically interacts with | ... | Q21126810 (Prostaglandin-endoperoxide synthase 1) | Prostaglandin-endoperoxide synthase 1 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P769 | significant drug interaction | ... | Q188543 (ammonium chloride) | ammonium chloride |
| P769 | significant drug interaction | ... | Q190016 (heparin) | heparin |
| P769 | significant drug interaction | ... | Q240642 (valproic acid) | valproic acid |
| P769 | significant drug interaction | ... | Q244408 (Diclofenac) | Diclofenac |
| P769 | significant drug interaction | ... | Q409672 ((RS)-citalopram) | (RS)-citalopram |
| P769 | significant drug interaction | ... | Q410237 (clopidogrel) | clopidogrel |
| P769 | significant drug interaction | ... | Q417222 (methylprednisolone) | methylprednisolone |
| P769 | significant drug interaction | ... | Q419890 ((±)-flurbiprofen) | (±)-flurbiprofen |
| P769 | significant drug interaction | ... | Q420262 (rivaroxaban) | rivaroxaban |
| P769 | significant drug interaction | ... | Q347941 (parecoxib) | parecoxib |
| P769 | significant drug interaction | ... | Q410400 (phenytoin) | phenytoin |
| P769 | significant drug interaction | ... | Q411932 ((S)-duloxetine) | (S)-duloxetine |
| P769 | significant drug interaction | ... | Q186969 (ibuprofen) | ibuprofen |
| P769 | significant drug interaction | ... | Q425207 (nabumetone) | nabumetone |
| P769 | significant drug interaction | ... | Q425289 (chlorthalidone) | chlorthalidone |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q407431 ((RS)-warfarin) | (RS)-warfarin |
| P769 | significant drug interaction | ... | Q407617 (sertraline) | sertraline |
| P769 | significant drug interaction | ... | Q420542 (ticagrelor) | ticagrelor |
| P769 | significant drug interaction | ... | Q422232 (methotrexate) | methotrexate |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q422252 (dexamethasone) | dexamethasone |
| P769 | significant drug interaction | ... | Q408163 (anagrelide) | anagrelide |
| P769 | significant drug interaction | ... | Q408471 (paroxetine) | paroxetine |
| P769 | significant drug interaction | ... | Q481757 (aceclofenac) | aceclofenac |
| P769 | significant drug interaction | ... | Q413690 (acetazolamide) | acetazolamide |
| P769 | significant drug interaction | ... | Q414028 (meloxicam) | meloxicam |
| P769 | significant drug interaction | ... | Q423930 (hydrochlorothiazide) | hydrochlorothiazide |
| P769 | significant drug interaction | ... | Q424972 (prednisone) | prednisone |
| P769 | significant drug interaction | ... | Q45050 (tenoxicam) | tenoxicam |
| P769 | significant drug interaction | ... | Q1640947 (phenindione) | phenindione |
| P769 | significant drug interaction | ... | Q1644947 (tenecteplase) | tenecteplase |
| P769 | significant drug interaction | ... | Q414275 (tolbutamide) | tolbutamide |
| P769 | significant drug interaction | ... | Q414462 (apixaban) | apixaban |
| P769 | significant drug interaction | ... | Q415220 (pemetrexed) | pemetrexed |
| P769 | significant drug interaction | ... | Q862989 (nicorandil) | nicorandil |
| P769 | significant drug interaction | ... | Q898407 (venlafaxine) | venlafaxine |
| P769 | significant drug interaction | ... | Q408676 (piroxicam) | piroxicam |
| P769 | significant drug interaction | ... | Q408801 (celecoxib) | celecoxib |
| P769 | significant drug interaction | ... | Q409192 ((RS)-ketoprofen) | (RS)-ketoprofen |
| P769 | significant drug interaction | ... | Q2465218 ((RS)-etodolac) | (RS)-etodolac |
| P769 | significant drug interaction | ... | Q2555245 ((RS)-fenoprofen) | (RS)-fenoprofen |
| P769 | significant drug interaction | ... | Q409231 (indomethacin) | indomethacin |
| P769 | significant drug interaction | ... | Q409236 (fluvoxamine) | fluvoxamine |
| P769 | significant drug interaction | ... | Q416132 (betamethasone) | betamethasone |
| P769 | significant drug interaction | ... | Q416485 (Streptokinase) | Streptokinase |
| P769 | significant drug interaction | ... | Q3563148 (vortioxetine) | vortioxetine |
| P769 | significant drug interaction | ... | Q5135114 ((2RS,6RS)-clopamide) | (2RS,6RS)-clopamide |
| P769 | significant drug interaction | ... | Q5984881 (ibrutinib) | ibrutinib |
| P769 | significant drug interaction | ... | Q900898 (probenecid) | probenecid |
| P769 | significant drug interaction | ... | Q963093 (sulindac) | sulindac |
| P769 | significant drug interaction | ... | Q1074056 (triamcinolone) | triamcinolone |
| P769 | significant drug interaction | ... | Q11426176 (prednisolone) | prednisolone |
| P769 | significant drug interaction | ... | Q1075324 (chlorpropamide) | chlorpropamide |
| P769 | significant drug interaction | ... | Q1078392 (indapamide) | indapamide |
| P769 | significant drug interaction | ... | Q1169164 ((RS)-bendroflumethiazide) | (RS)-bendroflumethiazide |
| P769 | significant drug interaction | ... | Q1215575 (naproxen) | naproxen |
| P769 | significant drug interaction | ... | Q27077698 (fondaparinux) | fondaparinux |
| P769 | significant drug interaction | ... | Q45769835 (alteplase) | alteplase |
| P279 | subclass of | ... | Q56085456 (benzoic acid) | benzoic acid |
| P279 | subclass of | ... | Q28417815 (acetate ester) | acetate ester |
| P2868 | subject has role | ... | Q188724 (non-steroidal anti-inflammatory drug) | non-steroidal anti-inflammatory drug |
| P2868 | subject has role | ... | Q173235 (analgesic) | analgesic |
| P2868 | subject has role | ... | Q582687 (antipyretic) | antipyretic |
| P2868 | subject has role | ... | Q721432 (platelet aggregation inhibitors) | platelet aggregation inhibitors |
| P2868 | subject has role | ... | Q72941151 (developmental toxicant) | developmental toxicant |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q7250944 (prostaglandin antagonist) | prostaglandin antagonist |
| P2868 | subject has role | ... | Q20522059 (cyclooxygenase inhibitors) | cyclooxygenase inhibitors |
| P2868 | subject has role | ... | Q50573636 (fibrinolytic agents) | fibrinolytic agents |
| P2868 | subject has role | ... | Q55427776 (female reproductive toxicant) | female reproductive toxicant |
| P910 | topic's main category | ... | Q8271402 (Category:Aspirin) | Category:Aspirin |
| P10 | video | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Synthesis%20of%20Aspirin%20Lab%20-%20NCSSM.webm | ??? |
| P6363 | WordLift URL | Url | None | ??? |
Why not click here or view trends?
log id: 1737627